Tech Company Financing Transactions
Ocera Therapeutics Funding Round
On 7/11/2006, Ocera Therapeutics raised $12 million in Series B financing from Sofinnova Ventures, Domain Associates, Thomas and McNerny & Partners.
Transaction Overview
Company Name
Announced On
7/11/2006
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series B
Investors
Proceeds Purpose
Funds will allow the company to continue the clinical development of its first product, AST-120, which already is in Phase III.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
525 University Avenue 610
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Website
Email Address
Overview
Ocera Therapeutics Inc. founded in January 2005, is a privately held, clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for gastrointestinal and liver diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Linda Grais
Chief Financial Officer
Michael Byrnes
VP - Sales
Gaurav Aggarwal
Browse more venture capital transactions:
Prev: 7/11/2006: Synta Pharmaceuticals venture capital transaction
Next: 7/12/2006: MobiTV venture capital transaction
Share this article
About Our VC Transactions Data
We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs